Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome
- PMID: 27110520
- PMCID: PMC4819211
Effect of Omega-3 Supplementation on Visfatin, Adiponectin, and Anthropometric Indices in Women with Polycystic Ovarian Syndrome
Abstract
Background: Polycystic ovary syndrome (PCOS) is a multifactorial, metabolic disorder. Characteristics are chronic anovulation, polycystic ovaries and hyperandrogenism. The aim of this study was to determine the effect of omega-3 supplementation on visfatin, adiponectin, and anthropometric indices in PCOS women.
Methods: The study was a randomized double blind placebo-controlled clinical trial. It was conducted on 84 women with polycystic ovary syndrome (26.92±5.05 years, BMI=31.69 Kg/m (2)) who referred to the fertility and infertility research center and Shahid Sadoughi hospital in Yazd. After the examination, evaluation and para-medical assessment by obstetrician, they were recruited. They took 3 capsules of omega-3 (each one contained 180 mg EPA and 120 mg DHA) or placebo (each contained 1 g paraffin) daily for 8 weeks. Statistical analysis was paired T-test and student T-test, and a p<0.05 was considered statistically significant.
Results: After the intervention, visfatin concentration did not change in neither groups. But, at the end of the study, the mean of adiponectin concentration increased (p<0.001) in omega-3 group. Moreover, the mean of changes in this factor was significantly different between groups (p<0.005). FSH did not change in two groups of the study. However, the mean of LH decreased about 1.74 mlU/ml in omega-3 group (p<0.005). The mean of change of LH/FSH ratio between groups was significant (p<0.05). After the intervention, prolactin did not meaningfully change in both groups.
Conclusion: Our results showed that 8 weeks of supplementation of omega-3 may have some beneficial effects on PCOS biochemical characteristics such as LH, LH/FSH, and adiponectin.
Keywords: Adiponectin; FSH; Fertility; LH; Obesity; Omega-3; PCOS; Visfatin.
Similar articles
-
Omega-3 fatty acids improve glucose metabolism without effects on obesity values and serum visfatin levels in women with polycystic ovary syndrome.J Am Coll Nutr. 2012 Oct;31(5):361-8. doi: 10.1080/07315724.2012.10720443. J Am Coll Nutr. 2012. PMID: 23529993 Clinical Trial.
-
Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.Asia Pac J Clin Nutr. 2012;21(4):511-8. Asia Pac J Clin Nutr. 2012. PMID: 23017309 Clinical Trial.
-
Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.Arch Gynecol Obstet. 2006 Jul;274(4):227-32. doi: 10.1007/s00404-006-0173-8. Epub 2006 May 12. Arch Gynecol Obstet. 2006. PMID: 16691383
-
Polycystic Ovary Syndrome.Obstet Gynecol. 2018 Aug;132(2):321-336. doi: 10.1097/AOG.0000000000002698. Obstet Gynecol. 2018. PMID: 29995717 Review.
-
Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.Diabetes Metab Syndr. 2017 Apr-Jun;11(2):157-162. doi: 10.1016/j.dsx.2016.06.025. Epub 2016 Jul 4. Diabetes Metab Syndr. 2017. PMID: 27484441 Review.
Cited by
-
N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications.EXCLI J. 2019 Jul 25;18:558-575. doi: 10.17179/excli2019-1534. eCollection 2019. EXCLI J. 2019. PMID: 31611740 Free PMC article. Review.
-
Effect of omega-3 supplements or diets on fertility in women: A meta-analysis.Heliyon. 2024 Apr 6;10(8):e29324. doi: 10.1016/j.heliyon.2024.e29324. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38628754 Free PMC article. Review.
-
The Influence of Nutrition on Adiponectin-A Narrative Review.Nutrients. 2021 Apr 21;13(5):1394. doi: 10.3390/nu13051394. Nutrients. 2021. PMID: 33919141 Free PMC article. Review.
-
Omega-3 fatty acids and L-carnitine prevent meiotic oocyte damage induced by follicular fluid from infertile women with endometriosis: an experimental study.JBRA Assist Reprod. 2023 Sep 28;27(4):610-8. doi: 10.5935/1518-0557.20230023. Online ahead of print. JBRA Assist Reprod. 2023. PMID: 37768816 Free PMC article.
-
Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome.Nutrients. 2024 Sep 3;16(17):2961. doi: 10.3390/nu16172961. Nutrients. 2024. PMID: 39275277 Free PMC article. Review.
References
-
- Witchel SF. Puberty and polycystic ovary syndrome. Mol Cell Endocrinol. 2006; 254– 255: 146– 53. - PubMed
-
- Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011; (7): CD007506. - PubMed
-
- Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl. 2006; 29 (1): 278– 85. - PubMed
-
- Xita N, Georgiou I, Tsatsoulis A. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol. 2002; 147 (6): 717– 25. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials